Dental Stem Cells SV40:源自人根尖乳头干细胞的永生化新细胞系
本研究用SV40大T抗原转染人根尖乳头干细胞(SCAPs),经嘌呤霉素筛选建立名为DSCS的永生化细胞系。DSCS在P25仍高表达CD73、CD90、CD105,增殖快于原代SCAPs(倍增时间23.46 h对40.31 h),可传代>45代并保持三系分化潜能。
要点
- DSCS在P25时CD73与CD90阳性率100%、CD105为98.9%,造血标记阳性<0.5%。
- DSCS倍增时间23.46 h,原代SCAPs为40.31 h,48 h后DSCS增殖增加。
- DSCS可生长>45代(150群体倍增),保持梭形形态与三系分化潜能。
核心结论
- 源自人SCAPs的新细胞系DSCS具有多向分化潜能,保留形态与间充质表面标记表达,即使在晚期传代(P45)仍显示更高的增殖能力。
- 作者认为DSCS细胞可用于牙根发育的体外研究,并有助于更好地理解再生机制。
研究设计与样本
- 体外研究:分离人SCAPs,用SV40大T抗原转染并以嘌呤霉素筛选感染群体,建立名为DSCS的细胞系。
- 在早期和晚期传代用流式细胞术检测人间充质表面标记CD73、CD90、CD105,并分析细胞接触抑制与增殖。
- 通过定量聚合酶链反应与组织学染色评估三系分化。
主要发现
- DSCS细胞流式细胞术证实即使晚期传代仍表达间充质表面标记:P25时CD73与CD90为100%阳性、CD105为98.9%阳性。
- 造血细胞标记CD45与CD34阳性率<0.5%。
- 48 h后DSCS细胞增殖较原代培养增加,DSCS细胞倍增时间为23.46 h,SCAPs为40.31 h。
- DSCS细胞保持生长>45代(150群体倍增)的能力及梭形形态。
- 组织化学染色与基因表达证实三系分化潜能:软骨标志SOX9与COL2A1、脂肪标志CEBPA与LPL、成骨标志COL1A1与ALPL。
关键数值与推荐
- P25时CD73与CD90阳性率100%,CD105阳性率98.9%。
- CD45与CD34阳性率<0.5%。
- DSCS细胞倍增时间23.46 h,原代SCAPs为40.31 h。
- DSCS细胞可生长>45代(150群体倍增)。
临床怎么用
- 原文结论认为DSCS细胞可用于牙根发育的体外研究,并有助于更好地理解再生机制。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To establish and fully characterize a new cell line from human stem cells of the apical papilla (SCAPs) through immortalization with an SV40 large T antigen. METHODOLOGY: Human SCAPs were isolated and transfected with an SV40 large T antigen and treated with puromycin to select the infected population. Expression of human mesenchymal surface markers CD73, CD90 and CD105 was assessed in the new cell line named Dental Stem Cells SV40 (DSCS) by flow cytometry at early and late passages. Cell contact inhibition and proliferation were also analysed. To evaluate trilineage differentiation, quantitative polymerase chain reaction and histological staining were performed. RESULTS: DSCS cell flow cytometry confirmed the expression of mesenchymal surface markers even in late passages [100% positive for CD73 and CD90 and 98.9% for CD105 at passage (P) 25]. Fewer than 0.5% were positive for haematopoietic cell markers (CD45 and CD34). DSCS cells also showed increased proliferation when compared to the primary culture after 48 h, with a doubling time of 23.46 h for DSCS cells and 40.31 h for SCAPs, and retained the capacity to grow for >45 passages (150 population doubling) and their spindle-shaped morphology. Trilineage differentiation potential was confirmed through histochemical staining and gene expression of the chondrogenic markers SOX9 and COL2A1, adipogenic markers CEBPA and LPL, and osteogenic markers COL1A1 and ALPL. CONCLUSIONS: The new cell line derived from human SCAPs has multipotency, retains its morphology and expression of mesenchymal surface markers and shows higher proliferative capacity even at late passages (P45). DSCS cells can be used for in vitro study of root development and to achieve a better understanding of the regenerative mechanisms.
引用
- Sanz-Serrano D, Sánchez-de-Diego C, Mercade M, et al. Dental Stem Cells SV40, a new cell line developed in vitro from human stem cells of the apical papilla. Int Endod J. 2023. PMID: 36585930. doi:10.1111/iej.13887
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。